HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infection by Leishmania infantum in cats: epidemiological study in Spain.

Abstract
More than 40 cases of feline leishmaniasis have been reported in the scientific literature. The influence of some immunodepressive conditions of viral origin, such as leukemia and feline immunodeficiency, are still unknown. The purpose of this study was to assess the prevalence of Leishmania infection in cats and possible relations with these viral infections. Markers of Leishmania infection were searched in 183 cats from Southern Spain by IFAT, PCR, Giemsa stain and culture, with a follow-up of positive cats. Seropositivity was 60.0% (Ab titer > or =10) and 28.3% of animals presented Ab titers > or =40. Around 25.7% of the cats studied were parasitemic and some of them remained positive for months. Combining both data, 70.6% of the feline population was, or could be, infected. We observed a negative association between seropositivity to Leishmania and infection by FeLV. Hence, production of antibodies against the parasite appears to be compromised in cats with leukemia, which have a prevalence of 36% in our study. In contrast, we found no association with feline immunodeficiency. The results makes us doubt the value of conventional serological methods to detect active Leishmania infection in cats.
AuthorsJ Martín-Sánchez, C Acedo, M Muñoz-Pérez, B Pesson, O Marchal, F Morillas-Márquez
JournalVeterinary parasitology (Vet Parasitol) Vol. 145 Issue 3-4 Pg. 267-73 (Apr 30 2007) ISSN: 0304-4017 [Print] Netherlands
PMID17157440 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
Topics
  • Animals
  • Antibodies, Protozoan
  • Cat Diseases (epidemiology, parasitology)
  • Cats
  • Fluorescent Antibody Technique, Indirect (veterinary)
  • Leishmania infantum (isolation & purification)
  • Leishmaniasis, Visceral (epidemiology, veterinary)
  • Polymerase Chain Reaction (veterinary)
  • Spain (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: